Frank L. Douglas

2.0k total citations
41 papers, 1.4k citations indexed

About

Frank L. Douglas is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Economics and Econometrics. According to data from OpenAlex, Frank L. Douglas has authored 41 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 7 papers in Molecular Biology and 5 papers in Economics and Econometrics. Recurrent topics in Frank L. Douglas's work include Pharmaceutical Economics and Policy (5 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Cardiac pacing and defibrillation studies (3 papers). Frank L. Douglas is often cited by papers focused on Pharmaceutical Economics and Policy (5 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Cardiac pacing and defibrillation studies (3 papers). Frank L. Douglas collaborates with scholars based in United States, Switzerland and Canada. Frank L. Douglas's co-authors include Ernst R. Berndt, Mark Trusheim, V. K. Narayanan, Leon I. Goldberg, Miklós Palkovits, Ashok Rakhit, Robert G. Ridley, Louis Maes, Bernadette Ramirez and Reto Brun and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Nature Reviews Drug Discovery.

In The Last Decade

Frank L. Douglas

40 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank L. Douglas United States 19 244 213 165 157 147 41 1.4k
Richard E. Miller United States 22 554 2.3× 93 0.4× 174 1.1× 147 0.9× 39 0.3× 91 1.9k
Susan Hahn United States 19 528 2.2× 104 0.5× 106 0.6× 80 0.5× 260 1.8× 59 3.0k
Ruth March United Kingdom 14 567 2.3× 101 0.5× 276 1.7× 197 1.3× 117 0.8× 29 2.1k
Zulfiqar Ali India 24 437 1.8× 207 1.0× 336 2.0× 149 0.9× 35 0.2× 118 2.7k
Markus Hinder Germany 19 257 1.1× 302 1.4× 36 0.2× 168 1.1× 120 0.8× 48 1.1k
Gerard Burke Ireland 33 424 1.7× 57 0.3× 393 2.4× 54 0.3× 303 2.1× 144 3.5k
Xiaotao Zhang China 25 181 0.7× 77 0.4× 146 0.9× 166 1.1× 147 1.0× 111 1.7k
David Mercer United States 30 373 1.5× 168 0.8× 815 4.9× 44 0.3× 141 1.0× 183 2.9k
Marina Bianchi Italy 31 849 3.5× 507 2.4× 371 2.2× 133 0.8× 49 0.3× 92 3.6k
Edward F. Smith United States 23 328 1.3× 338 1.6× 104 0.6× 20 0.1× 49 0.3× 78 1.7k

Countries citing papers authored by Frank L. Douglas

Since Specialization
Citations

This map shows the geographic impact of Frank L. Douglas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank L. Douglas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank L. Douglas more than expected).

Fields of papers citing papers by Frank L. Douglas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank L. Douglas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank L. Douglas. The network helps show where Frank L. Douglas may publish in the future.

Co-authorship network of co-authors of Frank L. Douglas

This figure shows the co-authorship network connecting the top 25 collaborators of Frank L. Douglas. A scholar is included among the top collaborators of Frank L. Douglas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank L. Douglas. Frank L. Douglas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lindsey, Merry L. & Frank L. Douglas. (2025). The evolution of chemical biology into translational physiology and precision medicine. American Journal of Physiology-Cell Physiology. 329(5). C1681–C1688. 1 indexed citations
2.
Wei, Hong-Jian, Alexander T.H. Wu, Yi-Ping Lin, et al.. (2011). The Development of a Novel Cancer Immunotherapeutic Platform Using Tumor-targeting Mesenchymal Stem Cells and a Protein Vaccine. Molecular Therapy. 19(12). 2249–2257. 27 indexed citations
3.
Douglas, Frank L., et al.. (2010). The case for entrepreneurship in R&D in the pharmaceutical industry. Nature Reviews Drug Discovery. 9(9). 683–689. 24 indexed citations
4.
Orloff, John J., Frank L. Douglas, José Cirı́aco Pinheiro, et al.. (2009). The future of drug development: advancing clinical trial design. Nature Reviews Drug Discovery. 8(12). 949–957. 110 indexed citations
5.
Douglas, Frank L., et al.. (1993). Increased blood-brain barrier permeability of amino acids in chronic hypertension. Life Sciences. 53(25). PL417–PL420. 18 indexed citations
6.
Douglas, Frank L., et al.. (1992). Vasodilatory effects of adenosine A2 receptor agonists CGS 21680 and CGS 22492 in human vasculature. European Journal of Pharmacology. 221(2-3). 243–247. 29 indexed citations
7.
Stephen, S., Louis L. Martin, Ashok Rakhit, et al.. (1992). Effects of thromboxane synthase inhibition with CGS 13080 in human cyclosporine nephrotoxicity. Kidney International. 41(1). 199–205. 37 indexed citations
8.
Singh, K. Chandramani, et al.. (1991). Determination of in vivo hepatic extraction ratio from in vitro metabolism by rat hepatocytes.. Drug Metabolism and Disposition. 19(5). 990–996. 10 indexed citations
9.
Martin, Louis L., et al.. (1991). Pharmacokinetics of CGS 12970 and inihibition of thromboxane synthesis after oral administration in healthy adults. Clinical Pharmacology & Therapeutics. 49(4). 433–441. 3 indexed citations
10.
O’Byrne, E. M., V. Blancuzzi, Douglas E. Wilson, et al.. (1991). Magnetic resonance imaging of the rabbit knee: Detection of cartilage proteoglycan degradation. Inflammation Research. 34(1-2). 214–216. 16 indexed citations
11.
Ross, Michael, et al.. (1990). Fetal and maternal response to intravenous infusion of a thromboxane synthetase inhibitor. American Journal of Obstetrics and Gynecology. 163(4). 1345–1349. 7 indexed citations
12.
Rakhit, Ashok, D. I. Jones, Alvin N. Kotake, et al.. (1990). Pharmacokinetic Screening of o-Naphthoquinone 5-Lipoxygenase Inhibitors. Pharmaceutical Research. 7(10). 1071–1076. 4 indexed citations
13.
14.
Foster, Clarence E., et al.. (1990). Magnesium aspartate HCl and magnesium chloride hexahydrate OROS: Comparative absorption of magnesium in dogs. Drug Development Research. 21(4). 291–300. 3 indexed citations
15.
Kotake, Alvin N., et al.. (1990). Effects of CGS-15943A on the relaxations produced by adenosine analogs in human blood vessels. European Journal of Pharmacology. 187(3). 525–530. 8 indexed citations
16.
17.
Rajfer, Sol I., et al.. (1987). Sustained hemodynamic improvement during long-term therapy with levodopa in heart failure: Role of plasma catecholamines. Journal of the American College of Cardiology. 10(6). 1286–1293. 36 indexed citations
18.
19.
Keiser, Harry R., D. S. Goldstein, James L. Wade, Frank L. Douglas, & Steven D. Averbuch. (1985). Treatment of malignant pheochromocytoma with combination chemotherapy.. Hypertension. 7(3_pt_2). I18–24. 79 indexed citations
20.
Douglas, Frank L. & Miklós Palkovits. (1982). Distribution and quantitative measurements of somatostatin-like immunoreactivity in the lower brainstem of the rat. Brain Research. 242(2). 369–373. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard E. Miller Breakdown of academic impact, for papers by Susan Hahn Breakdown of academic impact, for papers by Ruth March Breakdown of academic impact, for papers by Zulfiqar Ali Breakdown of academic impact, for papers by Markus Hinder Breakdown of academic impact, for papers by Gerard Burke Breakdown of academic impact, for papers by Xiaotao Zhang Breakdown of academic impact, for papers by David Mercer Breakdown of academic impact, for papers by Marina Bianchi Breakdown of academic impact, for papers by Edward F. Smith
Rankless by CCL
2026